MAASTRO clinic
Maastricht, Netherlands
NCT Number: NCT01855191
Introducing standardized data collection (SDC) for lung cancer patients to improve the performance of the prediction models.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Maastricht, Netherlands
All patients planned for curative primary or postoperative radiotherapy can be included. Patients will be treated according to the institutional protocol. It is optional to collect a saliva sample for genetic profiling.
Follow up at five time points:
At these time points, toxicity will be assessed. In addition, patients will receive a short questionnaire by mail at eight time points.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 24 months after RT
Time frame: during 24 months after RT
Time frame: During 24 months after RT
Time frame: During 24 months after RT
Time frame: During 24 months after RT
Measured by Euroqol questionnaire
Maastricht Radiation Oncology
Other
Standardized Data Collection (SDC) for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation (SDC Lung).
Acronym: SDC lung
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00340405
Lung Cancer, Lung Diseases
Beijing, China
View Trial DetailsNCT03117946
Head and Neck Cancer, Head and Neck Neoplasms
Besançon, France
View Trial DetailsNCT05832008
Adherence, Patient, Behavior
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06084208
Lung Cancer, Lung Diseases
Nijmegen, Netherlands
View Trial Details